Cases Where FDA Rejected a Drug Endorsed by Advisory Panel [Added entry for Contrave. Note: this table does not purport to be exhaustive.][pre] Panel Vote Date of FDA Ultimate iHub Company Drug For Approval Non-approval Resolution Reference AMGN Prolia 15-0‡ 10/09 apprvd 06/10 #msg-50796707 AZN Brilinta 7-1 7/10 pending #msg-57939117 BMY Belatacept 13-5 5/10 pending #msg-49686117 DNDN Provenge 13-4 5/07 apprvd 05/10 #msg-19483904 ITMN Pirfenidone 9-3 5/10 pending #msg-49777513 MRK Bridion 14-0 8/08 pending #msg-31141155 OREX Contrave 13-7 2/11 ? #msg-59389692 PFE Oporia 9-3 1/09 pending #msg-34890112 Roche Actemra 10-1 12/08 apprvd 01/10 #msg-33965815 ‡15-0 vote was for treatment of postmenopausal osteoporosis; vote on prevention of postmenopausal osteoporosis was 12-3. [/pre]